Ying Qu

机构：China Pharmaceutical University, National Medical Products Administration, Simcere Pharmaceutical (China), Shanghai Institute of Technology · ORCID：0000-0002-6668-9248

发表论文 17 篇 · 总被引 55 次 · h-index 4

代表论文

• Advances in Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia (2024 · Small · 被引 19)
• Melphalan-loaded methoxy poly(ethylene glycol)-poly(d,l-lactide) copolymer nanomicelles in the treatment of multiple myeloma (2023 · Chinese Chemical Letters · 被引 12)
• Application of biomaterials in cardiac tissue engineering: Current status and prospects (2024 · MedComm – Biomaterials and Applications · 被引 9)
• Liposome-Encapsulated Melphalan Exhibits Potent Antimyeloma Activity and Reduced Toxicity (2022 · ACS Omega · 被引 7)
• Rational Design and Biological Evaluation of a Novel Polθ Polymerase Inhibitor for Synergistic Targeting of HR-Deficient Cancers (2025 · Journal of Medicinal Chemistry · 被引 2)
• Preparation, characterization and application of long-chain fatty alcohol-based polymeric micelles (2022 · Materials Express · 被引 2)